FAPI PET for monitoring of rheumatological treatment in multifocal peritoneal nodular fibrosis: a case study

Eur J Nucl Med Mol Imaging. 2025 Jan 6. doi: 10.1007/s00259-024-07052-7. Online ahead of print.

Lena M Unterrainer^{1

2

3}, Stephan T Ledderose⁴, Sophie C Kunte^{5

6}, Johannes Toms⁵, Clemens C Cyran⁷, Adrien Holzgreve^{5

8}, Marcus Unterrainer^{5

9}, Hendrik Schulze-Koops¹⁰

¹ Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. [email protected].
² Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. [email protected].
³ Bavarian Cancer Research Center (BZKF), Partner Site Munich, Munich, Germany. [email protected].
⁴ Institute of Pathology, LMU Munich, Munich, Germany.
⁵ Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
⁶ Bavarian Cancer Research Center (BZKF), Partner Site Munich, Munich, Germany.
⁷ Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
⁸ Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
⁹ Die Radiologie, Munich, Germany.
¹⁰ Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, LMU Munich, Munich, Germany.

No abstract available